Related Content
Learn more
poster
A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma
Learn more
poster
Unique Insights into PDAC Development Revealed by Both InSituPlex and Imaging Mass Cytometry
Presented at SITC 2021
Learn more
poster
A multiplex immunofluorescence assay to assess immune checkpoint inhibitor targeted CD8 activation and tumor co-localization in FFPE tissues Copy
Learn more
poster
Design and application of an 8-plex multiplex immunofluorescence panel for deep phenotypic profiling of the tumor microenvironment using InSituPlex technology
Presented at AACR 2020
